This is a medicine used to lower eye pressure in people with glaucoma. It's a type of eye drop.
Every report comes from a Lived member, sent anonymously.
Have you tried Brimonidine Tartrate for Glaucoma?
Brimonidine tartrate is a prescription eye drop that lowers the pressure inside the eye in people with open-angle glaucoma or ocular hypertension. Open-angle glaucoma, the most common type, usually develops when fluid pressure in the eye slowly rises and damages the optic nerve, which carries signals from the eye to the brain. Without treatment it gradually takes away side vision and can eventually cause blindness. Ocular hypertension means the pressure is higher than normal but the nerve has not yet been damaged. Lowering eye pressure is the main treatment for both, because it slows or helps prevent that damage. The brand-name drops are Alphagan P, in 0.1% and 0.15% strengths, and generic versions are widely available. The original Alphagan 0.2% brand has been discontinued in the US, but generic 0.2% drops are still prescribed. The 0.2% strength is also part of two prescription combination drops: Combigan, which adds timolol (a beta blocker eye drop), and Simbrinza, which adds brinzolamide (another drop that reduces fluid production in the eye). The combination drops also carry the warnings of their added ingredient (for timolol, asthma and certain heart conditions), which are worth discussing with the prescriber. The same ingredient appears in two products with entirely different purposes. Mirvaso is a prescription skin gel that reduces the persistent facial redness of rosacea in adults. Lumify is a much weaker over-the-counter eye drop that relieves eye redness from minor irritation; it is not a glaucoma treatment.
The front of the eye is filled with a clear fluid called aqueous humor, which the eye continually produces and drains away. When drainage cannot keep pace, pressure builds. Brimonidine activates alpha-2 receptors, part of the nerve-signaling system that helps control blood vessels and fluid production. In the eye this has two effects: the eye makes less fluid, and more fluid leaves through a secondary drainage route. The pressure-lowering effect peaks about two hours after a drop, so the drops are used on a regular schedule through the day. Some of each drop is absorbed into the bloodstream, which is why brimonidine can cause effects away from the eye, such as dry mouth, tiredness and lower blood pressure. In Mirvaso gel, brimonidine works by narrowing the small blood vessels in the facial skin. This reduces visible redness for several hours, but it targets redness only and does not change the underlying rosacea.
For glaucoma or ocular hypertension, the usual prescription is one drop in each affected eye three times a day, about 8 hours apart. Using the drops at the same times each day keeps the effect steady. If a dose is missed, use it when you remember, unless the next dose is almost due; do not use a double dose to catch up. Many people use more than one eye medicine. Wait at least 5 minutes between different drops. After putting in a drop, close the eye for 2 to 3 minutes and press gently on the inner corner near the nose (the tear duct). Do not let the bottle tip touch the eye or any surface, and replace the cap after each use, because contaminated drops can cause a serious eye infection. Do not use the solution if it turns cloudy or changes color. If you have eye surgery, an eye injury or an eye infection while using the drops, contact your eye doctor promptly to ask whether to keep using the same bottle. Mirvaso is applied once a day as a thin, even layer: a pea-sized amount for each of five areas of the face (forehead, chin, nose and each cheek), avoiding the eyes and lips. Wash your hands right after applying it, and do not put it on irritated skin or open wounds. Lumify is for occasional over-the-counter use in adults and children 5 and older: follow the package directions, and stop and see a doctor if you have eye pain, changes in vision, or redness or irritation that worsens or lasts more than 3 days.
With the eye drops, the most common problems are in the eye itself: redness, itching, burning or stinging, and an allergic reaction of the eye's lining (allergic conjunctivitis). In clinical trials, roughly 1 in 10 to 1 in 5 people had allergic conjunctivitis, redness or itching. An eye allergy can look like red, itchy, swollen or watery eyes and lids. Tell the eye doctor rather than putting up with it, because other glaucoma drops are available. Dry mouth, tiredness, drowsiness, headache and blurred vision for a few minutes after a drop are also common. Drowsiness has the most practical impact. Until you know how the drops affect you, take care with driving or other activities that need full alertness. With Mirvaso, the main side effects are on the skin: flushing, redness and burning. Some people find that redness returns worse than before as the gel wears off, or appears in new areas such as the neck or chest; others notice excessive paleness. These effects usually settle after stopping the gel. Rarely, the gel has caused a serious allergic reaction. Swelling of the face, tongue or throat, or throat tightening, needs emergency care.
Brimonidine eye drops must not be used in babies or children under 2. In infants, they have caused slowed or paused breathing, a slow heart rate, low blood pressure, low body temperature, floppiness and coma. Children aged 2 to 6 are also sensitive: in a study of the 0.2% drops in this age group, half or more became markedly sleepy. Keep the drops and Mirvaso gel out of children's reach. Two young children who swallowed the gel needed hospital care for breathing problems and a slow heart rate. If a child swallows either product or a baby is given the eye drops, call Poison Control (1-800-222-1222) right away, and call 911 if the child is hard to wake or is breathing slowly or irregularly. Alcohol, sleeping pills, opioids, sedatives and anesthesia can add to brimonidine's drowsiness. Because brimonidine can lower blood pressure, it is used with caution alongside blood pressure medicines and digoxin (a heart medicine). The 0.2% drops should not be used by anyone taking a monoamine oxidase (MAO) inhibitor, an older type of antidepressant; with the 0.1% and 0.15% drops, an MAO inhibitor needs the prescriber's review because it may add to the blood pressure lowering. Tricyclic antidepressants may in theory interfere with the drops' effect, so tell the prescriber if you take one. Tell a surgeon or dentist that you use brimonidine before a procedure, because sedation and anesthesia can add to its drowsiness and blood pressure lowering. People with depression, reduced blood flow to the heart or brain, Raynaud's phenomenon (fingers or toes that turn white or blue in the cold), dizziness on standing, or severe heart disease should discuss whether brimonidine suits them, since it may worsen circulation-related problems. With Mirvaso, serious drops in heart rate and blood pressure have been reported, sometimes when the gel was used on skin just treated with a laser. The eye drops are not recommended while breastfeeding, because brimonidine could cause sedation or breathing problems in a nursing baby. Information on use in pregnancy is limited, so the decision rests on how much the eye pressure needs controlling. Anyone who has had an allergic reaction to brimonidine or a product's ingredients should not use it.
Raised eye pressure and early glaucoma often cause no symptoms, so you will not feel the drops working. Progress is measured at the eye doctor's office: pressure checks, and over time, tests of the optic nerve and side vision. In clinical trials, brimonidine lowered eye pressure by about 3.6 millimeters of mercury (mmHg, the unit eye pressure is measured in) more than a placebo drop, on average after three months. That is similar to timolol and somewhat less than prostaglandin drops such as latanoprost. Whether it is enough depends on the target pressure the eye doctor sets for your eyes, since the pressure the optic nerve can tolerate differs from person to person. Glaucoma treatment is usually long-term. The drops control eye pressure but do not cure glaucoma, so keep using them even when your eyes feel fine, and talk to the doctor before stopping. A three-times-a-day schedule is a real commitment. If the schedule or side effects are a problem, say so, because other drops, combination drops, laser treatment and surgery are all options. With Mirvaso, the effect lasts for hours and gradually fades, so redness returns each day. In trials, about a quarter to a third of people using the gel had redness drop by two grades on the doctors' and patients' rating scales (for example, from moderate to almost clear) three hours after applying it, compared with about one in ten using a plain gel.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Brimonidine Tartrate, what you've noticed, or ask the community a question.